Pathologic Complete response
Effect of neoadjuvant chemotherapy regimen on relapse free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de escalation of neoadjuvant chemotherapy
10
Radiologic complete response (rCR) in contrast enhanced magnetic resonance imaging (CE MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence free survival but not pathologic complete response (pCR)
11
Better pathologic complete response and relapse-free survival after carboplatin plus paclitaxel compared with epirubicin plus paclitaxel as neoadjuvant chemotherapy for locally advanced triple-negative breast cancer: a randomized phase 2 trial
10
Pathologic Complete Response (pCR) and Survival of Women with Inflammatory Breast Cancer (IBC): An Analysis Based on Biologic Subtypes and Demographic Characteristics
14
Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer
15
Clinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer
7
<p>Prediction of Pathologic Complete Response by Ultrasonography and Magnetic Resonance Imaging After Neoadjuvant Chemotherapy in Patients with Breast Cancer</p>
10
Density of CD8+ lymphocytes in biopsy samples combined with the circulating lymphocyte ratio predicts pathologic complete response to chemoradiotherapy for rectal cancer
8
Pathologic complete response after preoperative anti HER2 therapy correlates with alterations in PTEN, FOXO, phosphorylated Stat5, and autophagy protein signaling
10
Meta analysis on the association between pathologic complete response and triple negative breast cancer after neoadjuvant chemotherapy
12
Molecular characterization of patients with pathologic complete response or early failure after neoadjuvant chemotherapy for locally advanced breast cancer using next generation sequencing and nCounter assay
12
The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review
13
<p>A Case with Rectal Cancer Relapses After Clinical Complete Remission Following Neoadjuvant Chemoradiotherapy</p>
6
Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials
8
The triple negative paradox_Primary tumor chemosensitivity of breast cancer subtypes.pdf
6
Current neoadjuvant treatment options for HER2 positive breast cancer
8
Fluorouracil-based neoadjuvant chemoradiotherapy with or without oxaliplatin for treatment of locally advanced rectal cancer: An updated systematic review and meta-analysis
12
NSABP FB 7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer
11
A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
10
Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer
9